Hypoxia inducible factor 1 (HIF-1) and cardioprotection.
about
Cellular and molecular basis of RV hypertrophy in congenital heart diseaseThe Role of Oxygen Sensors, Hydroxylases, and HIF in Cardiac Function and DiseaseHIF hydroxylase pathways in cardiovascular physiology and medicineZinc promotes the death of hypoxic astrocytes by upregulating hypoxia-induced hypoxia-inducible factor-1alpha expression via poly(ADP-ribose) polymerase-1Mild hypoxia-induced cardiomyocyte hypertrophy via up-regulation of HIF-1α-mediated TRPC signallingSCF increases cardiac stem cell migration through PI3K/AKT and MMP‑2/‑9 signalingGenome Resequencing Identifies Unique Adaptations of Tibetan Chickens to Hypoxia and High-Dose Ultraviolet Radiation in High-Altitude Environments.Impaired transcriptional response of the murine heart to cigarette smoke in the setting of high fat diet and obesity.Disruption of hypoxia-inducible transcription factor-prolyl hydroxylase domain-1 (PHD-1-/-) attenuates ex vivo myocardial ischemia/reperfusion injury through hypoxia-inducible factor-1α transcription factor and its target genes in mice.Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses.Admission hypoxia-inducible factor 1α levels and in-hospital mortality in patients with acute decompensated heart failure.The genetic basis for survivorship in coronary artery disease.Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus.Nitric oxide and hypoxia stimulate erythropoietin receptor via MAPK kinase in endothelial cellsModulation of hypoxia-inducible factors (HIF) from an integrative pharmacological perspective.HIF-prolyl hydroxylases and cardiovascular diseases.Ischemia-induced copper loss and suppression of angiogenesis in the pathogenesis of myocardial infarction.Intermittent hypoxia training in prediabetes patients: Beneficial effects on glucose homeostasis, hypoxia tolerance and gene expression.Editor's Choice- Inside the cold heart: A review of therapeutic hypothermia cardioprotection.Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hypertension.Cellular mechanisms underlying cardiac engraftment of stem cells.The association of depressed angiogenic factors with reduced capillary density in the Rhesus monkey model of myocardial ischemia.Intrinsic remote conditioning of the myocardium as a comprehensive cardiac response to ischemia and reperfusion.Ω3 Supplementation and intermittent hypobaric hypoxia induce cardioprotection enhancing antioxidant mechanisms in adult rats.Intermittent hypobaric hypoxia applicability in myocardial infarction prevention and recovery.Engineered myocardium model to study the roles of HIF-1α and HIF1A-AS1 in paracrine-only signaling under pathological level oxidative stress.Correlation between genetic polymorphisms within the MAPK1/HIF-1/HO-1 signaling pathway and risk or prognosis of perimenopausal coronary artery disease.Molecular mechanisms of cardioprotective effects mediated by transplanted cardiac ckit+ cells through the activation of an inflammatory hypoxia-dependent reparative response.HIF-1α, VEGF, and EGFR: contributing factors in the pathogenesis of necrotizing sialometaplasia.Up-regulation of iNOS by hypoxic postconditioning inhibits H9c2 cardiomyocyte apoptosis induced by hypoxia/re-oxygenation.Apigenin ameliorates hypertension-induced cardiac hypertrophy and down-regulates cardiac hypoxia inducible factor-lα in rats.Assessment of HIF-1α expression and release following endothelial injury in-vitro and in-vivo.Metabolic Suppression of HIF-1α Contributes to Susceptibility of Ischemic Injury in Diabetic Hearts
P2860
Q26777913-58615915-2B81-4875-8D9C-15D545BAF560Q26780548-F6B0B424-6F5C-4F3D-A9A9-D60CECC870CCQ26862091-B4722EEB-7919-434B-A6BA-B845F1E96EC6Q28569225-4B410276-ABAA-4223-A6D5-0BE922EB7B67Q28580076-35E6D89C-34B6-47AB-8FC6-DABA520180F1Q33811230-D6614D2E-160F-482C-A734-E8E817DBB8B4Q34515298-2457BC2D-44A4-4464-944D-5516D270AAFBQ34523438-A28F2E9B-E82F-440B-BDD2-4D718762C979Q35173596-FFE513AB-4200-4F88-BE09-EBE961420A6CQ35671282-1CCBE97E-504F-450E-BD3F-E1B184E89AE0Q35724664-42BF64DF-D8E0-4863-9FD7-F9B5A9E8A1D1Q37201894-D67E6851-2C7A-4D2C-9DB5-59CBF5175A27Q37680288-54BB9E3E-B514-4726-A950-347EAEC2DFD8Q37696218-6A644C29-FF2D-460A-8D5E-E9FCBA9545ADQ37943792-5E2C18A0-4B29-4E30-A989-4A936A5BA2C0Q37994258-F94BC2E0-8B48-4B9C-82F3-D2055BD63326Q38014352-1D43871B-062C-4473-82F4-BBAE2EC31B4DQ38652332-5E268505-3D23-430F-8B13-8745EC0444F8Q38682413-72ED2917-DE61-4D64-B00F-7BA74610135CQ38792819-DF9FCE4E-14D7-47EC-B845-2C4C7A8A3B49Q39266683-04430490-CD60-4753-9388-85370EDD3332Q39410733-B6B57FFA-2416-4134-A992-E93F788D0BD2Q40017141-50423540-B27A-4FDD-9133-79556A4105B7Q42366539-719B4CF5-3C40-4BEC-8B6F-8246241A867EQ43167524-A808547A-8036-4061-8590-2AABFDFEAFEAQ43193972-3A5414DB-F127-485E-9BFC-E6FC6BE5D97EQ48004345-5564C5B4-0806-46AF-9477-4BDFBD1E35C9Q48230146-5D544881-4A73-4338-8DAC-3285E9AAC36AQ50054706-AA2C0807-DD8E-4085-B520-3C14A8239C5FQ50849487-E87C8887-D002-4E49-B78B-6FC19C1EA470Q53480521-75DC65D7-CD70-4405-9800-594901315245Q55026648-2A4EBE2C-0F0F-4739-A828-B17A80E60049Q55502652-1E59702C-A784-459B-BE9B-94CE63D2E814Q58698760-B98CBB26-F8A5-4868-BC5F-EE630242B0FF
P2860
Hypoxia inducible factor 1 (HIF-1) and cardioprotection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hypoxia inducible factor 1 (HIF-1) and cardioprotection.
@en
Hypoxia inducible factor 1
@nl
type
label
Hypoxia inducible factor 1 (HIF-1) and cardioprotection.
@en
Hypoxia inducible factor 1
@nl
prefLabel
Hypoxia inducible factor 1 (HIF-1) and cardioprotection.
@en
Hypoxia inducible factor 1
@nl
P2093
P2860
P356
P1476
Hypoxia inducible factor 1 (HIF-1) and cardioprotection.
@en
P2093
P2860
P2888
P304
P356
10.1038/APS.2010.132
P577
2010-08-16T00:00:00Z
P5875
P6179
1005770576